We must however note that the phenotypes we have observed here are resulting from reductions in Dctn1 levels well below the 50% reduction that is expected in ALS patients harbouring damaging variants in one copy of the DCTN1 gene. This evidence concerns the gene DCTN1 and amyotrophic lateral sclerosis.